At 35.1x earnings and 21.1x forward earnings, ACMR is priced as a growth compounder, yet the 1.4 forward PEG suggests that growth is not outrageously overvalued relative to expectations. The 3.3 Altman Z-Score signals low near-term bankruptcy risk, reinforced by a 3.3 current ratio and modest 12.10% debt/equity, so balance sheet stress is not the issue. However, with a 6.40% operating margin and 6.10% ROIC, profitability is not elite for a semiconductor equipment name, which makes the 35.1 P/E look demanding unless earnings acceleration materializes. The market is not deeply mispricing it; it’s assigning a reasonable growth premium to a financially stable but not exceptional operator.